Cystatin C is a predictor for long-term All-Cause and Cardiovascular Mortality in US Adults with Metabolic Syndrome
CONCLUSION: MetS patients with elevated CysC levels have a higher risk of all-cause, CVD, and cancer death. CysC may predict MetS all-cause and CVD mortality.PMID:38597157 | DOI:10.1210/clinem/dgae225
Source: The Journal of Clinical Endocrinology and Metabolism - Category: Endocrinology Authors: Xiaoying Song Lijiao Xiong Tianting Guo Xue Chen Pinjun Zhang Xiaoan Zhang Zhen Liang Source Type: research
More News: Cancer | Cancer & Oncology | Cardiology | Cardiovascular | Endocrinology | Heart | Metabolic Syndrome | Nutrition | Study